| Bioactivity | HCoV-OC43-IN-1 (Compound IV-16) is a coronavirus HCoV-OC43 inhibitor. HCoV-OC43-IN-1 has antiviral efficacy (EC50: 90 nM). HCoV-OC43-IN-1 inhibits the mRNA level and expression of viral nucleocapsid protein (NP)[1]. |
| Name | HCoV-OC43-IN-1 |
| CAS | 2809363-81-1 |
| Formula | C23H22F6N4O2 |
| Molar Mass | 500.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhou S, et al. Design, synthesis, and structure-activity relationships of a novel class of quinazoline derivatives as coronavirus inhibitors. Eur J Med Chem. 2023 Sep 25;261:115831. |
HCoV-OC43-IN-1
CAS: 2809363-81-1 F: C23H22F6N4O2 W: 500.44
HCoV-OC43-IN-1 (Compound IV-16) is a coronavirus HCoV-OC43 inhibitor. HCoV-OC43-IN-1 has antiviral efficacy (EC50: 90 nM
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.